Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Howard

Showing results (51-60 of 265) with videos related to

Pageof 27
Sort By:
Psychological Medicine|January 9, 2023
Antidepressant medications in dementia: evidence and potential mechanisms of treatment-resistanceHarry Costello, Jonathan P Roiser, Robert Howard
International Journal of Geriatric Psychiatry|August 4, 2004
Have risk factors for very late-onset schizophrenia-like psychosis changed in the last 40 years?Francisco Romero-Rubiales, Suzanne Reeves, Robert Howard
The Journal of Prevention of Alzheimer'S Disease|February 21, 2026
Long-term extension data do not robustly support clinical disease course modification with donanemabJemma Hazan, Kathy Y Liu, Robert Howard
Neurology|February 11, 2009
Increased striatal dopamine (D2/D3) receptor availability and delusions in Alzheimer diseaseSuzanne Reeves, Richard Brown, Robert Howard, et al.
Journal of Psychosocial Nursing and Mental Health Services|October 10, 2017
Very Late-Onset Schizophrenia-Like Psychosis: A Clinical UpdateElizabeth Cort, Jennifer Meehan, Suzanne Reeves, et al.
Journal of Alzheimer'S Disease : JAD|May 17, 2017
Efficacy of Antidepressants for Depression in Alzheimer's Disease: Systematic Review and Meta-AnalysisVasiliki Orgeta, Naji Tabet, Ramin Nilforooshan, et al.
International Journal of Geriatric Psychiatry|July 26, 2017
Reduced parahippocampal volume and psychosis symptoms in Alzheimer's diseaseEmma McLachlan, Jennifer Bousfield, Robert Howard, et al.
The Lancet. Psychiatry|June 4, 2021
The need to show minimum clinically important differences in Alzheimer's disease trialsKathy Y Liu, Lon S Schneider, Robert Howard
The Lancet. Psychiatry|November 21, 2021
Time to acknowledge good electroconvulsive therapy researchTania Gergel, Robert Howard, Rebecca Lawrence, et al.
International Journal of Geriatric Psychiatry|January 8, 2022
Practical application of Alzheimer's Disease Neuroimaging Initiative plasma P-tau181 reference data to support diagnosis of Alzheimer's diseaseJemma Hazan, Duncan Alston, Nick C Fox, et al.
Pageof 27

Showing results (51-60 of 265) with videos related to

Sort By:
Pageof 27
Psychological Medicine|January 9, 2023
Antidepressant medications in dementia: evidence and potential mechanisms of treatment-resistanceHarry Costello, Jonathan P Roiser, Robert Howard
International Journal of Geriatric Psychiatry|August 4, 2004
Have risk factors for very late-onset schizophrenia-like psychosis changed in the last 40 years?Francisco Romero-Rubiales, Suzanne Reeves, Robert Howard
The Journal of Prevention of Alzheimer'S Disease|February 21, 2026
Long-term extension data do not robustly support clinical disease course modification with donanemabJemma Hazan, Kathy Y Liu, Robert Howard
Neurology|February 11, 2009
Increased striatal dopamine (D2/D3) receptor availability and delusions in Alzheimer diseaseSuzanne Reeves, Richard Brown, Robert Howard, et al.
Journal of Psychosocial Nursing and Mental Health Services|October 10, 2017
Very Late-Onset Schizophrenia-Like Psychosis: A Clinical UpdateElizabeth Cort, Jennifer Meehan, Suzanne Reeves, et al.
Journal of Alzheimer'S Disease : JAD|May 17, 2017
Efficacy of Antidepressants for Depression in Alzheimer's Disease: Systematic Review and Meta-AnalysisVasiliki Orgeta, Naji Tabet, Ramin Nilforooshan, et al.
International Journal of Geriatric Psychiatry|July 26, 2017
Reduced parahippocampal volume and psychosis symptoms in Alzheimer's diseaseEmma McLachlan, Jennifer Bousfield, Robert Howard, et al.
The Lancet. Psychiatry|June 4, 2021
The need to show minimum clinically important differences in Alzheimer's disease trialsKathy Y Liu, Lon S Schneider, Robert Howard
The Lancet. Psychiatry|November 21, 2021
Time to acknowledge good electroconvulsive therapy researchTania Gergel, Robert Howard, Rebecca Lawrence, et al.
International Journal of Geriatric Psychiatry|January 8, 2022
Practical application of Alzheimer's Disease Neuroimaging Initiative plasma P-tau181 reference data to support diagnosis of Alzheimer's diseaseJemma Hazan, Duncan Alston, Nick C Fox, et al.
Pageof 27